Skip to content

Innoveren Scientific, Inc.

CIK 0001591165

← back to feed
Revenue (TTM)
$1.36M
−71.9% YoY Q3 Nov 2023
Net Income (TTM)
−$4.04M
−114.6% YoY Q3 Nov 2023
EPS Diluted (TTM)
−$19.97
Q3 Nov 2023
Gross Margin
65.4%
Q3 Nov 2023
Operating Margin
-227.7%
Q3 Nov 2023
Net Margin
-296.5%
Q3 Nov 2023
Free Cash Flow (TTM)
−$4.65M
Q3 Nov 2023
Cash
$150K
Q3 Nov 2023
Total Debt
$594.62K
Q3 Nov 2023
Shares Outstanding
712.71K sh
Q3 Nov 2023

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings